Works matching IS 09441174 AND DT 2021 AND VI 56 AND IP 6

Results: 7

Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.
Published in:
2021
By:
- Shinzaki, Shinichiro;
- Matsuoka, Katsuyoshi;
- Tanaka, Hiroki;
- Takeshima, Fuminao;
- Kato, Shingo;
- Torisu, Takehiro;
- Ohta, Yuki;
- Watanabe, Kenji;
- Nakamura, Shiro;
- Yoshimura, Naoki;
- Kobayashi, Taku;
- Shiotani, Akiko;
- Hirai, Fumihito;
- Hiraoka, Sakiko;
- Watanabe, Mamoru;
- Matsuura, Minoru;
- Nishimoto, Shohei;
- Mizuno, Shinta;
- Iijima, Hideki;
- Takehara, Tetsuo
Publication type:
journal article
Experiment on endoscopic balloon dilation for esophageal stenosis after endoscopic submucosal dissection in pigs.
Published in:
2021
By:
- Kinowaki, Sayoko;
- Shimizu, Yuichi;
- Ono, Masayoshi;
- ZiJian, Yang;
- Tanaka, Ikko;
- Shimoda, Yoshihiko;
- Inoue, Masaki;
- Ishikawa, Marin;
- Yamamoto, Keiko;
- Ono, Shoko;
- Ohnishi, Shunsuke;
- Sakamoto, Naoya
Publication type:
journal article
Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer.
Published in:
2021
By:
- Shimada, Yoshifumi;
- Okuda, Shujiro;
- Watanabe, Yu;
- Tajima, Yosuke;
- Nagahashi, Masayuki;
- Ichikawa, Hiroshi;
- Nakano, Masato;
- Sakata, Jun;
- Takii, Yasumasa;
- Kawasaki, Takashi;
- Homma, Kei-ichi;
- Kamori, Tomohiro;
- Oki, Eiji;
- Ling, Yiwei;
- Takeuchi, Shiho;
- Wakai, Toshifumi
Publication type:
journal article
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.
Published in:
2021
By:
- Nakase, Hiroshi;
- Uchino, Motoi;
- Shinzaki, Shinichiro;
- Matsuura, Minoru;
- Matsuoka, Katsuyoshi;
- Kobayashi, Taku;
- Saruta, Masayuki;
- Hirai, Fumihito;
- Hata, Keisuke;
- Hiraoka, Sakiko;
- Esaki, Motohiro;
- Sugimoto, Ken;
- Fuji, Toshimitsu;
- Watanabe, Kenji;
- Nakamura, Shiro;
- Inoue, Nagamu;
- Itoh, Toshiyuki;
- Naganuma, Makoto;
- Hisamatsu, Tadakazu;
- Watanabe, Mamoru
Publication type:
journal article
Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas.
Published in:
2021
By:
- Kobayashi, Toshikazu;
- Omori, Yuko;
- Ono, Yusuke;
- Karasaki, Hidenori;
- Mizukami, Yusuke;
- Makino, Naohiko;
- Motoi, Fuyuhiko;
- Unno, Michiaki;
- Ueno, Yoshiyuki;
- Furukawa, Toru
Publication type:
journal article
Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
Published in:
2021
By:
- Nam, Kwangwoo;
- Kim, Nayoung;
- Song, Hyun Joo;
- Baik, Gwang Ho;
- Choi, Suck Chei;
- Kim, Hyun Jin;
- Lee, Ju Yup;
- Park, Kyung Sik;
- Park, Sun-Young;
- Park, Seun Ja
Publication type:
journal article
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.
Published in:
2021
By:
- Okusaka, Takuji;
- Ikeda, Kenji;
- Kudo, Masatoshi;
- Finn, Richard;
- Qin, Shukui;
- Han, Kwang-Hyub;
- Cheng, Ann-Lii;
- Piscaglia, Fabio;
- Kobayashi, Masahiro;
- Sung, Max;
- Chen, Minshan;
- Wyrwicz, Lucjan;
- Yoon, Jung-Hwan;
- Ren, Zhenggang;
- Mody, Kalgi;
- Dutcus, Corina;
- Tamai, Toshiyuki;
- Ren, Min;
- Hayato, Seiichi;
- Kumada, Hiromitsu
Publication type:
journal article

Works matching IS 09441174 AND DT 2021 AND VI 56 AND IP 6

Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.

Experiment on endoscopic balloon dilation for esophageal stenosis after endoscopic submucosal dissection in pigs.

Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer.

Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.

Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas.

Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.

Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.